Liquid-Based Cervical Cytology: Monitoring the Laboratory Quality Indicators

Overview

Journal J Cytol

Specialty Cell Biology

Date 2024 Jan 29

PMID 38282808

Authors

Sonali Susmita Nayak

Anupurva Dutta

Rutvij Khedkar

Sabyasachi Roy

Affiliations

Soon will be listed here.

Abstract

Aim: Many developments in cervical cancer screening have happened in the past century, helping women in earlier detection of cervical cancer and its precursors. Cytology still holds the fort as being a specific test, though it suffers in sensitivity. As a part of the quality control program, the aim of the study is to determine the total number of abnormal liquid-based cervical cytology (LBC) at our center and correlate the abnormal LBC with histology and human papillomavirus (HPV) DNA test results.

Method: Retrospective analysis of 4286 LBC screening cases was carried out over a period of 5 years. For cytology-histology correlation, cervical biopsy and cytology test results were analyzed. The two-tier grading system for biopsy interpretation was used. HPV DNA test results wherever available were correlated.

Results: Of the 4286 LBC cases, 157 samples (3.7%) were unsatisfactory for evaluation, 3915 samples (91.3%) were negative for intra-epithelial lesion or malignancy, and 214 samples (5%) showed epithelial cell abnormality. ASC-US was reported in 60 cases (1.4%), ASC-H in 35 cases (0.8%), LSIL in 47 cases (1.1%), HSIL in 41 cases (1.0%), squamous cell carcinoma in a single case (0.02%), and atypical glandular cells in 30 cases (0.7%). The ASC/SIL ratio was 1.07:1. The CHC major discrepancy was calculated as 16.2%. The concordance of HSIL on cytology and biopsy as a measure of PPV is 94.4%. Of the epithelial cell abnormalities, 24 cases were positive for high-risk HPV (hrHPV). Molecular test results of 2737 samples showed HPV detected in 50 cases, of which 24 cases were positive for hrHPV.

Conclusion: The study helped us to analyze the quality parameters of our cytopathology laboratory which are within the acceptable limits.

References

Stoler M . ASC, TBS, and the power of ALTS. Am J Clin Pathol. 2007; 127(4):489-91. DOI: 10.1309/J31A0YQM37Q4V4KK. View

Crothers B . Cytologic-histologic correlation: Where are we now, and where are we going?. Cancer Cytopathol. 2018; 126(5):301-308. DOI: 10.1002/cncy.21991. View

Herbert A, Johnson J, Patnick J . Achievable standards, benchmarks for reporting and criteria for evaluating cervical cytopathology. Cytopathology. 1995; 6(5):301-3. DOI: 10.1111/j.1365-2303.1995.tb00575.x. View

Auger M . A selection of monitoring parameters for gynecologic cytology-Beacons of light for quality assurance. Cancer Cytopathol. 2013; 122(1):3-4. DOI: 10.1002/cncy.21349. View

Howell L, Nayar R, Savaloja L, Tabbara S, Thomas N, Winkler B . The role of proficiency testing in ensuring quality: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 3. Arch Pathol Lab Med. 2013; 137(2):183-9. DOI: 10.5858/arpa.2012-0094-OA. View

Waxman A, Chelmow D, Darragh T, Lawson H, Moscicki A . Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix. Obstet Gynecol. 2012; 120(6):1465-71. PMC: 4054813. DOI: 10.1097/aog.0b013e31827001d5. View

Crothers B, Jones B, Cahill L, Moriarty A, Mody D, Tench W . Quality improvement opportunities in gynecologic cytologic-histologic correlations: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 4. Arch Pathol Lab Med. 2013; 137(2):199-213. DOI: 10.5858/arpa.2012-0250-OA. View

Renshaw A, Deschenes M, Auger M . ASC/SIL Ratio for Cytotechnologists: A surrogate marker of screening sensitivity. Am J Clin Pathol. 2009; 131(6):776-81. DOI: 10.1309/AJCPXANG59GPHJNU. View

Jones B, Novis D . Cervical biopsy-cytology correlation. A College of American Pathologists Q-Probes study of 22 439 correlations in 348 laboratories. Arch Pathol Lab Med. 1996; 120(6):523-31. View

10.

Nascimento A, Cibas E . The ASC/SIL ratio for cytopathologists as a quality control measure: a follow-up study. Am J Clin Pathol. 2007; 128(4):653-6. DOI: 10.1309/APTVNLP1P0X00CUQ. View

11.

Perkins R, Guido R, Saraiya M, Sawaya G, Wentzensen N, Schiffman M . Summary of Current Guidelines for Cervical Cancer Screening and Management of Abnormal Test Results: 2016-2020. J Womens Health (Larchmt). 2021; 30(1):5-13. PMC: 8020523. DOI: 10.1089/jwh.2020.8918. View